cover
Contact Name
Zulfiayu Sapiun
Contact Email
zulfiayu@poltekkesgorontalo.ac.id
Phone
+6281244521639
Journal Mail Official
jecp@poltekkesgorontalo.ac.id
Editorial Address
Gedung Jurusan Farmasi Politeknik Kesehatan Kementerian Kesehatan Gorontalo Jln, Taman Pendidikan, Kecamatan Kota Timur, Kota Gorontalo, Gorontalo 96113
Location
Kota gorontalo,
Gorontalo
INDONESIA
Journal of Experimental and Clinical Pharmacy (JECP)
ISSN : -     EISSN : 27751368     DOI : https://doi.org/10.52365/JECP
Core Subject : Health, Science,
Journal of Experimental and Clinical Pharmacy (JECP) merupakan jurnal yang issue tiap 6 bulan sekali (Februari-Agustus) dalam bidang farmasi eksperimen dan farmasi klinik secara nasional. Penelitian eksperimental dalam jurnal ini mencakup penelitian pengembangan obat dan makanan secara in vivo, in vitro, in silico, dan formulasi serta pemeriksaan mutu makanan. Sementara itu, penelitian klinis mencakup uji klinik, case report, case series, cohort, dan crossectional dari penggunaan obat obatan dan kosmetika. Kami juga menerima artikel penelitian mengenai farmasi komunitas dan entreprenuer pharmacy (Pharmaprenuer). Selain artikel penelitian, kami juga menerima karya dalam bentuk review artikel, mini review dan Short Communication. Jurnal ini adalah jurnal akses terbuka Jurnal ini adalah jurnal akses terbukadan tidak memungut biaya publikasi untuk berlangganan, pengiriman, dan penerbitan jurnal.
Articles 82 Documents
Overview of Pneumonia Treatment in Hospitalized Geriatric Patients at One of the Gorontalo Provincial Hospitals: Case Report Papeo, ⁠Dizky Ramadani Putri; Kai, Mohamad Nur Fadjri; Isa, Moh. Arya Avrilio; Sumaga, Nabila Natasya; Mursidi, Sitti Rahmawaty Sisilia; Canon, Afifah Aliya
Journal of Experimental and Clinical Pharmacy (JECP) Vol 5, No 2 (2025): August 2025
Publisher : Poltekkes Kemenkes Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52365/jecp.v5i2.1445

Abstract

Pneumonia is a common respiratory infection affecting all age groups, particularly the elderly, who are more susceptible due to comorbidities and age-related decline in immune function. This case report aims to evaluate the role of clinical pharmacy in the management of community-acquired pneumonia (CAP) in a geriatric patient. A descriptive qualitative method was conducted through retrospective analysis of medical records, including clinical presentation, diagnostic findings, pharmacological and non-pharmacological interventions, and patient outcomes. The pharmacological therapy included ceftriaxone and azithromycin as antibiotics, mucolytics, bronchodilators, antipyretics, gastrointestinal protection, and vitamin supplementation, with clinical pharmacy involvement in therapy optimization and monitoring. Non-pharmacological strategies involved oxygen therapy, semi-Fowler positioning, effective coughing techniques, and hydration support. The patient showed marked clinical improvement with increased SpO₂ from 95% to 98%, a reduction in respiratory rate from 30 to 22 breaths/minute, and symptom resolution by day four. This report highlights that the integration of clinical pharmacy interventions significantly contributes to effective and safer management of CAP in elderly patients
Overview of Antipsychotic Use in Schizophrenia Patients at the East City Health Center in 2024 Tuloli, Teti Sutriyati; Makkulawu, Andi; Sumaga, Khairunnisa Alya; Madania, Madania; Manno, Mohamad Reski
Journal of Experimental and Clinical Pharmacy (JECP) Vol 5, No 2 (2025): August 2025
Publisher : Poltekkes Kemenkes Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52365/jecp.v5i2.1388

Abstract

Schizophrenia is a severe mental disorder that affects individuals and greatly impacts their families and society, with symptoms like hallucinations, delusions, and emotional or thought disturbances that disrupt daily life and well-being. Treatment for schizophrenia usually involves a combination of antipsychotic drug therapy, psychotherapy, and social support. This study aims to determine the description of antipsychotic use, including the type of drug, rules of use, drug dosage, and duration of use in schizophrenia patients at the Kota Timur Health Center. This study used a descriptive observational research design with data collection using a retrospective method. The research data were obtained from secondary data in the form of medical record data from as many as 25 patients with mental illness. The data were processed with Excel and analyzed using SPSS version 26. The results showed that schizophrenia was predominantly suffered by male patients (56%), and more were in the age range of 34-46 years (as many as 48%). The most widely used antipsychotic drugs were a combination of typical and atypical, as many as 92%. The most frequently used type of drug is clozapine with a dose of 25 mg, and the rules of use are 2 x 1/2 as much as 46%. The longest duration of treatment is already in the maintenance phase, which is 96%. Additional drug trihexyphenidyl 2 mg (2 x 1) is used as much as 92%. The most widely used type of therapy is 3-combination therapy, namely Risperidone + THP + Clozapine, as much as 56%. This study was conducted at the East City Health Center, Gorontalo, which is one of the largest primary healthcare facilities in the region and manages a considerable number of schizophrenia patients with limited psychiatric resources. Therefore, the study setting provides important insights into the real-world use of antipsychotic medications in a community-based healthcare center.